scispace - formally typeset
Open AccessJournal ArticleDOI

Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk.

Reads0
Chats0
TLDR
Gut microbes, through generation of trimethylamine N-oxide (TMAO), directly contribute to platelet hyperreactivity and enhanced thrombosis potential, revealing a previously unrecognized mechanistic link between specific dietary nutrients, gut microbes, platelet function, and thromBosis risk.
About
This article is published in Cell.The article was published on 2016-03-24 and is currently open access. It has received 1219 citations till now. The article focuses on the topics: Platelet activation & Trimethylamine N-oxide.

read more

Citations
More filters
Journal ArticleDOI

Significant correlation between the gut microbiota-derived metabolite trimethylamine-N-oxide and the risk of stroke: evidence based on 23 observational studies

TL;DR: A meta-analysis quantitatively summarized the results of studies that investigated the association between TMAO and stroke and revealed the positive association between circulating TMAo and stroke.
Journal ArticleDOI

Trimethylamine N-oxide reduction is related to probiotic strain specificity: A systematic review.

TL;DR: In this paper , a systematic review aimed to evaluate the effect of probiotics to mitigate TMAO concentrations by gut microbiota modulation and concluded that Lactobacillus rhamnosus GG were the most efficient strains in reducing the plasma TMAI level in both humans and animals.
Journal ArticleDOI

Intestinal Flora Derived Metabolites Affect the Occurrence and Development of Cardiovascular Disease

TL;DR: In this paper , a review of the role of the Gut microbiota and its metabolites in the development of CVDs is presented, focusing on the production and metabolism of trimethylamine N-oxide (TMAO) and short-chain fatty acids (SCFAs).
Journal ArticleDOI

Intestinal Flora Derived Metabolites Affect the Occurrence and Development of Cardiovascular Disease

TL;DR: In this article , a review of the role of the Gut Microbiota and their metabolites in the development of cardiovascular diseases is presented, focusing on the production and metabolism of trimethylamine N-oxide (TMAO) and short-chain fatty acids (SCFAs).
Journal ArticleDOI

Relationship between the coronary artery calcium quantification and gut microbiota composition in subjects without previous cardiovascular disease: A pilot study.

TL;DR: In this article , the authors investigated the relationship between gut microbiota composition and the presence of coronary atherosclerosis assessed by coronary artery calcium (CAC) quantification in individuals without previous cardiovascular disease (CVD).
References
More filters
Journal ArticleDOI

An obesity-associated gut microbiome with increased capacity for energy harvest

TL;DR: It is demonstrated through metagenomic and biochemical analyses that changes in the relative abundance of the Bacteroidetes and Firmicutes affect the metabolic potential of the mouse gut microbiota and indicates that the obese microbiome has an increased capacity to harvest energy from the diet.
Journal ArticleDOI

The gut microbiota as an environmental factor that regulates fat storage

TL;DR: In this article, the authors found that conventionalization of adult germ-free C57BL/6 mice with a normal microbiota harvested from the distal intestine (cecum) of conventionally raised animals produces a 60% increase in body fat content and insulin resistance within 14 days despite reduced food intake.
Journal ArticleDOI

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

TL;DR: Discovery of a relationship between gut-flora-dependent metabolism of dietary phosphatidylcholine and CVD pathogenesis provides opportunities for the development of new diagnostic tests and therapeutic approaches for atherosclerotic heart disease.
Journal ArticleDOI

Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk

TL;DR: The production of TMAO from dietary phosphatidylcholine is dependent on metabolism by the intestinal microbiota and increased levels are associated with an increased risk of incident major adverse cardiovascular events.
Related Papers (5)